Anixa Biosciences Stock Forum

$Anixa Biosciences(ANIX.US)$ Reuters· 7 mins ago
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

$Anixa Biosciences(ANIX.US)$
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Anixa Biosciences (NASDAQ: ANIX) announced that its collaborator, Cleveland Clinic, has received a 'Decision to Grant' notice from the Japan Patent Office for a patent application on breast cancer vaccine technology.
This extends the patent protection to Japan, in addition to existing U.S. and European patents.
Anixa is the exclusive worldwide licensee of this technology.
The vacci...

$Anixa Biosciences(ANIX.US)$
Anixa Biosciences Announces $5 Million Share Repurchase Program

Anixa Biosciences: Current Developments and Future Prospects.
On Monday, H.C. Wainwright & Co. adjusted its outlook on Anixa Biosciences (NASDAQ: ANIX) shares, reducing the 12-month price target to $7.00 from the previous $12.00 while maintaining a Buy rating. This adjustment is based on a recent financial report and a new partnership focused on cancer vaccine development. $Anixa Biosciences(ANIX.US)$
https://stockregion.app/p/prominent-investment-bank-maintains

$Anixa Biosciences(ANIX.US)$
NEWS
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences has commenced treatment of the fifth patient in its Phase 1 clinical trial for CAR-T therapy targeting ovarian cancer. This trial, conducted in partnership with Moffitt Cancer Center, enrolls female patients with recurrent ovarian cancer unresponsive to at least two prior therapies. The trial aims to identify the maximum tolerated dose of T-cells targe...

$Anixa Biosciences(ANIX.US)$
NEWS
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines